CellVantage™ AAV Starter Kit
Three-molecule AAV enhancer kit designed for expanded capability across multiple HEK293-based suspension platforms. Delivers 2–6× higher titers, with flexibility and potential for stacked benefits in HEK293-based cell lines across transfection conditions. Read More
Best for: research and production teams working across diverse suspension HEK293 platforms and seeking a versatile enhancer toolkit.
Optimize with more flexibility. Deliver with more confidence.
Have any questions? Contact an Expert
| Specifications | |
|---|---|
| Cell Line | HEK293-based |
| Application | AAV Production |
| Transfection Reagents | Optimal for PEI-based |
| Culture Type | Suspension |
| Appearance | White Powder |
| Stability | 24 months |
| Storage | 20 ± 5ºC, protect from light |
| Production System | Transient and Stable |
The CellVantage™ AAV Starter Kit was specifically designed to improve AAV manufacturing in suspension HEK293-based systems. For other viral vector applications, please contact Virica to discuss the best-fit enhancer from our portfolio. Contact an Expert
A single vial of each enhancer can treat up to 3L of production media at the recommended starting dose. Production volume may vary depending on the optimal dose for a given manufacturing system. Enhancers should be evaluated individually and in pairwise combinations to identify the best-performing condition.
If required, CellVantageTM Starter Kit enhancers may be diluted immediately prior to use in a solution between 100% and 50% DMSO (v/v in media). This can be done to increase pipettable volume and/or minimize DMSO carryover into cell culture. These intermediate working stocks should be be prepared immediately before use and promptly added into the final application. Freezing or reusing working stock solutions is not recommended.
There is no specific solvent provided with the CellVantage™ AAV Starter Kit. For dissolving purposes, any 100% tissue culture grade DMSO can be used. For specific inquiries, please contact Virica’s technical team directly.
Options are available for adherent cell production platforms. Please contact us to discuss the best-fit solution for your workflow.
Yes. Please contact Virica directly for information on bulk order formats for larger manufacturing scales, as well as GMP availability and pricing.
For typical transfection-based processes, CellVantage™ AAV Starter Kit enhancers are added once and remain in the media throughout upstream production. Re-addition should only be considered if a full media exchange is performed within 4 hours of transfection complex addition. Please consult Virica for application-specific guidance or Contact an Expert.
No. CellVantage™ AAV Starter Kit enhancers can remain in the media for the duration of viral production.
Research-grade CellVantage™ AAV Starter Kit enhancers are not routinely tested for sterility. It should be dissolved in a sterile environment, such as a biological safety cabinet (BSC). Sterile filtration is not recommended or required when testing dose ranges during small-scale formulation development. If sterile filtration is required, please consult Virica for recommended filter types before proceeding.
The enhancers should be added at the time of transfection for transient workflows, or at the time of induction for stable producer cell lines. Where needed, addition within a ±30-minutes of the transfection or induction event is generally acceptable.